AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases

AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases
nhigginsdunn
Wed, 07/21/2021 – 11:05